About F-box only protein 9
F-box only protein 9 (FBXO9) is a protein
from Homo sapiens identified by UniProt accession
Q9UK97, 447 residues long.
MolForge cross-references it against 0 known binders and
42 disease associations.
Target properties
| Protein name | F-box only protein 9 |
| UniProt accession | Q9UK97 |
| Gene | FBXO9 |
| Organism | Homo sapiens |
| Length | 447 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (42)
Diseases linked to this target (Open Targets).
- smoking status measurement · score 0.20
- clear cell renal carcinoma · score 0.18
- pancreatic adenocarcinoma · score 0.18
- age at first sexual intercourse measurement · score 0.17
- smoking initiation · score 0.15
- acute myeloid leukemia · score 0.08
- neoplasm · score 0.08
- hepatocellular carcinoma · score 0.07
- cancer · score 0.06
- attention deficit hyperactivity disorder · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9UK97-F1 | alphafold | PREDICTED | 77.42 | — |
Amino-acid sequence (447 residues)
MPDIIWVFPP QAEAEEDCHS DTVRADDDEE NESPAETDLQ AQLQMFRAQW MFELAPGVSS SNLENRPCRA ARGSLQKTSA DTKGKQEQAK EEKARELFLK AVEEEQNGAL YEAIKFYRRA MQLVPDIEFK ITYTRSPDGD GVGNSYIEDN DDDSKMADLL SYFQQQLTFQ ESVLKLCQPE LESSQIHISV LPMEVLMYIF RWVVSSDLDL RSLEQLSLVC RGFYICARDP EIWRLACLKV WGRSCIKLVP YTSWREMFLE RPRVRFDGVY ISKTTYIRQG EQSLDGFYRA WHQVEYYRYI RFFPDGHVMM LTTPEEPQSI VPRLRTRNTR TDAILLGHYR LSQDTDNQTK VFAVITKKKE EKPLDYKYRY FRRVPVQEAD QSFHVGLQLC SSGHQRFNKL IWIHHSCHIT YKSTGETAVS AFEIDKMYTP LFFARVRSYT AFSERPL
Explore F-box only protein 9 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets